Articles by Daniel Marsh
Macquarie's Weekly Slide Erases A$4.96B, Analysts See Slim Upside
Macquarie shares dropped 5.14% last week, wiping out A$4.96B in market cap—more than its FY26 profit. Analysts see just 2.98% upside, with key support at A$247.36.
Healthcare Leads ASX Rotation as CSL Rebounds; Banks Struggle
Healthcare surged 9.2% on the ASX this week, led by CSL's strong results, while banks fell 5.1%. CPI and earnings will test the market next week.
Vertiv's $12.3B Slide Tests AI Valuation as Yields Surge
Vertiv (VRT) saw $12.3B wiped from its market value last week as rising yields pressured AI stocks. Shares fell 10.9%, testing the premium on AI-linked growth.
Tesla Jumps 5% on Nevada Robotaxi Approval, But Scaling Questions Remain
Tesla (TSLA) rallied 5.14% to $362.86 after Nevada granted a robotaxi permit allowing up to 5,000 vehicles, though the company's current unsupervised fleet is just 232, raising questions about near-term scalability.
GM, Unifor Reach Tentative Pact; Layoffs Cloud Ontario Outlook
GM and Unifor reached tentative deals covering 4,600 Ontario workers, averting a strike. However, 30% layoffs and plant uncertainties remain key investor concerns.
Constellation Energy Slips Despite Analyst Optimism
Constellation Energy shares dropped 3.4% this week, but analysts maintain targets above the close. Strong Q2 results and raised guidance underpin optimism.
Keel Stock Trades at 2.5x Liquidity as AI Lease Confirmation Lingers
Keel shares slipped 1.5% Friday to $3.32, trading at 2.5x liquidity. AI tenant confirmation remains outstanding, though permits are progressing.
Fannie Mae Stock Rises as Management Shakeup Fuels Governance Worries
Fannie Mae shares rose 1.62% to $6.29 on Friday after reports of senior executive departures, even as strong Q2 results highlighted a $176B capital shortfall.
Webster Financial's Final Session Marks End of Santander Acquisition
Webster Financial's shares ended at $77.57 on August 19, its final session, with volume 15.4 times the average. Santander's acquisition completed August 20, delisting WBS.
Moderna's Cancer Vaccine Rally Outpaces Wall Street Targets
Moderna's stock soared 129% in a week on positive cancer vaccine data, leaving analyst targets far behind. The average price target is 45.7% below the current price.
Gates Foundation Trust Discloses $352.68M Home Depot Stake
The Gates Foundation Trust disclosed a new 1 million-share stake in Home Depot (HD) valued at $352.68 million, but the filing does not indicate a personal purchase by Bill Gates.